Loading...
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221&222
Non-small cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers. While some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, up-regulated by the MET proto-oncogene, have been already described to enhance c...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3719419/ https://ncbi.nlm.nih.gov/pubmed/21706050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.260 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|